1. Home
  2. KEQU vs MRSN Comparison

KEQU vs MRSN Comparison

Compare KEQU & MRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kewaunee Scientific Corporation

KEQU

Kewaunee Scientific Corporation

N/A

Current Price

$37.62

Market Cap

124.6M

Sector

Industrials

ML Signal

N/A

Logo Mersana Therapeutics Inc.

MRSN

Mersana Therapeutics Inc.

HOLD

Current Price

$29.99

Market Cap

138.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KEQU
MRSN
Founded
1906
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
124.6M
138.8M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
KEQU
MRSN
Price
$37.62
$29.99
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$30.38
AVG Volume (30 Days)
7.5K
114.7K
Earning Date
12-10-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
3.94
N/A
Revenue
$285,515,000.00
$33,180,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$9.76
N/A
Revenue Growth
43.02
N/A
52 Week Low
$30.33
$5.21
52 Week High
$71.33
$36.25

Technical Indicators

Market Signals
Indicator
KEQU
MRSN
Relative Strength Index (RSI) 45.04 78.89
Support Level $37.10 $28.11
Resistance Level $38.29 $29.15
Average True Range (ATR) 1.04 0.57
MACD 0.09 -0.47
Stochastic Oscillator 34.22 48.68

Price Performance

Historical Comparison
KEQU
MRSN

About KEQU Kewaunee Scientific Corporation

Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.

About MRSN Mersana Therapeutics Inc.

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

Share on Social Networks: